Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease

MT Newswires Live

昨天

Biogen (BIIB) and Japanese pharmaceutical company Eisai said Monday that LEQEMBI IQLIK, a once-weekly autoinjector formulation of lecanemab-irmb, is now available in the US for initiation therapy in adults with early Alzheimer's disease.

The treatment is indicated for patients with mild cognitive impairment or mild dementia due to Alzheimer's disease.

The drug is administered using an autoinjector to provide 500 mg once a week in two consecutive 250 mg injections, with each injection taking about 15 seconds to deliver.

LEQEMBI IQLIK is available through the LEQEMBI Specialty Pharmacy Network, the companies said.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2661127910"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2661127910\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2661127910?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-24 20:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2661127910","market":"fut","top_or_hot":-1,"title":"Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease","media":"MT Newswires Live","content":"<html><body><p> Biogen (BIIB) and Japanese pharmaceutical company Eisai said Monday that LEQEMBI IQLIK, a once-weekly autoinjector formulation of lecanemab-irmb, is now available in the US for initiation therapy in adults with early Alzheimer's disease.</p><p>The treatment is indicated for patients with mild cognitive impairment or mild dementia due to Alzheimer's disease.</p><p>The drug is administered using an autoinjector to provide 500 mg once a week in two consecutive 250 mg injections, with each injection taking about 15 seconds to deliver.</p><p>LEQEMBI IQLIK is available through the LEQEMBI Specialty Pharmacy Network, the companies said.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen, Eisai's LEQEMBI IQLIK Now Available in US for Early Alzheimer's Disease\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-08-24 20:55</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Biogen (BIIB) and Japanese pharmaceutical company Eisai said Monday that LEQEMBI IQLIK, a once-weekly autoinjector formulation of lecanemab-irmb, is now available in the US for initiation therapy in adults with early Alzheimer's disease.</p><p>The treatment is indicated for patients with mild cognitive impairment or mild dementia due to Alzheimer's disease.</p><p>The drug is administered using an autoinjector to provide 500 mg once a week in two consecutive 250 mg injections, with each injection taking about 15 seconds to deliver.</p><p>LEQEMBI IQLIK is available through the LEQEMBI Specialty Pharmacy Network, the companies said.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票月供概念","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2661127910","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2661127910","pubTimestamp":1787576112,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Biogen  and Japanese pharmaceutical company Eisai said Monday that LEQEMBI IQLIK, a once-weekly autoinjector formulation of lecanemab-irmb, is now available in the US for initiation therapy in adults with early Alzheimer's disease.The treatment is indicated for patients with mild cognitive impairment or mild dementia due to Alzheimer's disease.The drug is administered using an autoinjector to provide 500 mg once a week in two consecutive 250 mg injections, with each injection taking about 15 seconds to deliver.LEQEMBI IQLIK is available through the LEQEMBI Specialty Pharmacy Network, the companies said.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","LU0320765992.SGD":"FTIF - Franklin Biotechnology Discovery A Acc SGD","BIIB":"渤健公司","LU0234570918.USD":"高盛全球核心股票组合Acc Close","LU0889565916.HKD":"FRANKLIN BIOTECHNOLOGY DISCOVERY \"A\" (HKD) ACC","BK4139":"生物科技","IE00B894F039.SGD":"Legg Mason ClearBridge - US Aggressive Growth A Acc SGD-H","BK4532":"文艺复兴科技持仓","PBE":"INVESCO BIOTECHNOLOGY & GENOME ETF","BK4533":"AQR资本管理(全球第二大对冲基金)","BMED":"iShares Health Innovation Active ETF","LU0109394709.USD":"富兰克林生物科技新领域基金A (acc)","IE00B19Z9Z06.USD":"Legg Mason ClearBridge - US Aggressive Growth A Acc USD","BK4588":"碎股","IE00B19Z9P08.USD":"LEGG MASON CLEARBRIDGE US AGGRESSIVE GROWTH \"A\" (USD) INC"},"translate_title":"百健、卫材的 LEQEMBI IQLIK 现已在美国上市，用于治疗早期阿尔茨海默病","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PBE":0.6,"BIIB":1.5,"BMED":0.6},"content_text":"Biogen (BIIB) and Japanese pharmaceutical company Eisai said Monday that LEQEMBI IQLIK, a once-weekly autoinjector formulation of lecanemab-irmb, is now available in the US for initiation therapy in adults with early Alzheimer's disease.The treatment is indicated for patients with mild cognitive impairment or mild dementia due to Alzheimer's disease.The drug is administered using an autoinjector to provide 500 mg once a week in two consecutive 250 mg injections, with each injection taking about 15 seconds to deliver.LEQEMBI IQLIK is available through the LEQEMBI Specialty Pharmacy Network, the companies said.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}